000 | 01881 a2200517 4500 | ||
---|---|---|---|
005 | 20250514074459.0 | ||
264 | 0 | _c20030905 | |
008 | 200309s 0 0 eng d | ||
022 | _a0091-6749 | ||
024 | 7 |
_a10.1067/mai.2003.1689 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGauvreau, Gail M | |
245 | 0 | 0 |
_aThe effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. _h[electronic resource] |
260 |
_bThe Journal of allergy and clinical immunology _cAug 2003 |
||
300 |
_a331-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAsthma _xcomplications |
650 | 0 | 4 |
_aBlood Proteins _xmetabolism |
650 | 0 | 4 |
_aBronchial Hyperreactivity _xdrug therapy |
650 | 0 | 4 |
_aBronchitis _xdrug therapy |
650 | 0 | 4 |
_aCD11a Antigen _ximmunology |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aEosinophil Granule Proteins |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aForced Expiratory Volume _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypersensitivity _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRibonucleases |
650 | 0 | 4 |
_aSputum _xcytology |
700 | 1 | _aBecker, Allan B | |
700 | 1 | _aBoulet, Louis-Philippe | |
700 | 1 | _aChakir, Jamila | |
700 | 1 | _aFick, Robert B | |
700 | 1 | _aGreene, William L | |
700 | 1 | _aKillian, Kieran J | |
700 | 1 | _aO'byrne, Paul M | |
700 | 1 | _aReid, John K | |
700 | 1 | _aCockcroft, Donald W | |
773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 112 _gno. 2 _gp. 331-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1067/mai.2003.1689 _zAvailable from publisher's website |
999 |
_c12673017 _d12673017 |